Page last updated: 2024-08-21

indazoles and Schizophrenia

indazoles has been researched along with Schizophrenia in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Bartyzel, A; Budzyńska, B; Castro, M; Chodkowski, A; Fornal, E; Kaczor, AA; Mirecka, K; Stępnicki, P; Szałaj, K; Targowska-Duda, KM; Turło, J; Wróbel, MZ; Wróbel, TM; Wronikowska-Denysiuk, O; Zięba, A	1
Garibaldi, G; Keefe, RS; Lowe, DA; Murray, S; Porter, R; Santarelli, L; Umbricht, D	1
Abi-Dargham, A; Jaskiw, GE; Kleinman, JE; Laruelle, M; Lipska, B; Robertson, DW; Weinberger, DR; Wong, DT	1

Trials

1 trial(s) available for indazoles and Schizophrenia

Article	Year
A randomized, placebo-controlled study investigating the nicotinic α7 agonist, RG3487, for cognitive deficits in schizophrenia. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2014, Volume: 39, Issue:7 Topics: Adolescent; Adult; Antipsychotic Agents; Bridged Bicyclo Compounds; Cognition Disorders; Double-Blind Method; Female; Humans; Indazoles; Male; Middle Aged; Neuropsychological Tests; Nicotinic Agonists; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Young Adult	2014

Article

Year

A randomized, placebo-controlled study investigating the nicotinic α7 agonist, RG3487, for cognitive deficits in schizophrenia.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2014, Volume: 39, Issue:7

Topics: Adolescent; Adult; Antipsychotic Agents; Bridged Bicyclo Compounds; Cognition Disorders; Double-Blind Method; Female; Humans; Indazoles; Male; Middle Aged; Neuropsychological Tests; Nicotinic Agonists; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Young Adult

2014

Other Studies

2 other study(ies) available for indazoles and Schizophrenia

Article	Year
Novel multi-target ligands of dopamine and serotonin receptors for the treatment of schizophrenia based on indazole and piperazine scaffolds-synthesis, biological activity, and structural evaluation. Journal of enzyme inhibition and medicinal chemistry, 2023, Volume: 38, Issue:1 Topics: Antipsychotic Agents; Dopamine; Humans; Indazoles; Ligands; Piperazine; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin; Schizophrenia; Serotonin	2023
Serotonin 5-HT3 receptors in schizophrenia: a postmortem study of the amygdala. Brain research, 1993, Jul-09, Volume: 616, Issue:1-2 Topics: Adult; Aged; Amygdala; Analysis of Variance; Animals; Autopsy; Female; Haloperidol; Hippocampus; Humans; Indazoles; Kinetics; Male; Middle Aged; Rats; Receptors, Serotonin; Reference Values; Schizophrenia; Serotonin Antagonists; Tropanes	1993

Article

Year

Novel multi-target ligands of dopamine and serotonin receptors for the treatment of schizophrenia based on indazole and piperazine scaffolds-synthesis, biological activity, and structural evaluation.

Journal of enzyme inhibition and medicinal chemistry, 2023, Volume: 38, Issue:1

Topics: Antipsychotic Agents; Dopamine; Humans; Indazoles; Ligands; Piperazine; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin; Schizophrenia; Serotonin

2023

Serotonin 5-HT3 receptors in schizophrenia: a postmortem study of the amygdala.

Brain research, 1993, Jul-09, Volume: 616, Issue:1-2

Topics: Adult; Aged; Amygdala; Analysis of Variance; Animals; Autopsy; Female; Haloperidol; Hippocampus; Humans; Indazoles; Kinetics; Male; Middle Aged; Rats; Receptors, Serotonin; Reference Values; Schizophrenia; Serotonin Antagonists; Tropanes

1993